Search

Your search keyword '"Johnson, Andrew C."' showing total 687 results

Search Constraints

Start Over You searched for: Author "Johnson, Andrew C." Remove constraint Author: "Johnson, Andrew C."
687 results on '"Johnson, Andrew C."'

Search Results

302. Source apportionment and crop bioaccumulation of perfluoroalkyl acids and novel alternatives in an industrial-intensive region with fluorochemical production, China: Health implications for human exposure.

303. Investigating the occurrence and fate of anticancer drugs in sewage treatment works and the wider aquatic environment

304. Fate and behaviour of Microplastics (> 25µm) within the water distribution network, from water treatment works to service reservoirs and customer taps.

305. A Horizon Scan to Support Chemical Pollution–Related Policymaking for Sustainable and Climate‐Resilient Economies

307. Multiple crop bioaccumulation and human exposure of perfluoroalkyl substances around a mega fluorochemical industrial park, China: Implication for planting optimization and food safety.

308. Transport and transformation of perfluoroalkyl acids, isomer profiles, novel alternatives and unknown precursors from factories to dinner plates in China: New insights into crop bioaccumulation prediction and risk assessment.

309. Multiple pollutants stress the coastal ecosystem with climate and anthropogenic drivers.

310. Patterns of invertebrate functional diversity highlight the vulnerability of ecosystem services over a 45-year period.

311. Neuroactive drugs and other pharmaceuticals found in blood plasma of wild European fish.

312. Managing health risks of perfluoroalkyl acids in aquatic food from a river-estuary-sea environment affected by fluorochemical industry.

313. Ecological risk assessment of fifty pharmaceuticals and personal care products (PPCPs) in Chinese surface waters: A proposed multiple-level system.

315. Pharmaceuticals in the Aquatic Environment: No Answers Yet to the Major Questions.

316. Type IV pilus retraction is required for Neisseria musculi colonization and persistence in a natural mouse model of infection.

317. Biological-Activity-Based Prioritization of Antidepressants in Wastewater in England and Japan.

318. Diabetic hyperglycemia promotes primary tumor progression through glycation-induced tumor extracellular matrix stiffening.

320. The Weight-of-Evidence Approach and the Need for Greater International Acceptance of Its Use in Tackling Questions of Chemical Harm to the Environment.

321. Identification and Quantification of Microplastics in Potable Water and Their Sources within Water Treatment Works in England and Wales.

322. Learning from the past and considering the future of chemicals in the environment.

323. Persistence and migration of tetracycline, sulfonamide, fluoroquinolone, and macrolide antibiotics in streams using a simulated hydrodynamic system.

324. What Works? the Influence of Changing Wastewater Treatment Type, Including Tertiary Granular Activated Charcoal, on Downstream Macroinvertebrate Biodiversity Over Time.

326. A restatement of the natural science evidence base on the effects of endocrine disrupting chemicals on wildlife.

327. The different fate of antibiotics in the Thames River, UK, and the Katsura River, Japan.

328. Predicting national exposure to a point source chemical: Japan and endocrine disruption as an example.

329. The arrival and discharge of conjugated estrogens from a range of different sewage treatment plants in the UK.

330. Natural variations in flow are critical in determining concentrations of point source contaminants in rivers: an estrogen example.

331. The use of modelling to predict levels of estrogens in a river catchment: how does modelled data compare with chemical analysis and in vitro yeast assay results?

332. Gas-liquid chromatography-tandem mass spectrometry methodology for the quantitation of estrogenic contaminants in bile of fish exposed to wastewater treatment works effluents and from wild populations.

333. Cytotoxic drugs in drinking water: a prediction and risk assessment exercise for the thames catchment in the United kingdom.

334. Exposure assessment of 17alpha-ethinylestradiol in surface waters of the United States and Europe.

335. Estrogen concentration affects its biodegradation rate in activated sludge.

336. Rapid determination of free and conjugated estrogen in different water matrices by liquid chromatography-tandem mass spectrometry.

337. The British river of the future: how climate change and human activity might affect two contrasting river ecosystems in England.

338. Do suspended sediments modulate the effects of octylphenol on rainbow trout?

339. A national risk assessment for intersex in fish arising from steroid estrogens.

340. 10th Anniversary Perspective: Reflections on endocrine disruption in the aquatic environment: from known knowns to unknown unknowns (and many things in between).

341. Meeting report: risk assessment of tamiflu use under pandemic conditions.

342. Assessing the concentrations of polar organic microcontaminants from point sources in the aquatic environment: measure or model?

344. What difference might sewage treatment performance make to endocrine disruption in rivers?

345. Potential risks associated with the proposed widespread use of Tamiflu.

346. Modeling effects of mixtures of endocrine disrupting chemicals at the river catchment scale.

347. Lessons from endocrine disruption and their application to other issues concerning trace organics in the aquatic environment.

348. A model to estimate influent and effluent concentrations of estradiol, estrone, and ethinylestradiol at sewage treatment works.

349. The ability of indigenous micro-organisms to degrade isoproturon, atrazine and mecoprop within aerobic UK aquifer systems.

350. Steroid estrogens profiles along river stretches arising from sewage treatment works discharges.

Catalog

Books, media, physical & digital resources